Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Study of Response of Medical Journal Editorial Boards to Notification of Serious Discrepancies in Published Clinical Trials in Human Patients.

NCT01901523 is registered in ClinicalTrials.gov with Imperial College London as lead sponsor.

NCT NCT01901523
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01901523 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Study of Response of Medical Journal Editorial Boards to Notification of Serious Discrepancies in Published Clinical Trials in Human Patients.
Lead sponsor
Imperial College London
Phase
Not applicable
Overall status
Unknown status
Start date
June 30, 2014
Completion date
December 31, 2015
Enrollment
15 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

heart failure